CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and can afford the risks. Trading CFDs is high risk and is not suitable for everyone. Refer to our PDS and Target Market Determination. AFSL 513393
Open platformOpen platform

PRESS DIGEST -Wall Street Journal - November 4

By Reuters News

Nov 4 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

- CVS Health CVS.N is testing a breakup that would separate its retail pharmacy business from its insurance operations.

- CVR Energy CVI.N, the oil refiner controlled by investor Carl Icahn, agreed to pay $4.2 billion to buy two refineries from Marathon Petroleum MPC.N.

- Industrial conglomerate 3M MMM.N said it would commit nearly $7.35 billion over nine years to settle PFAS "forever chemicals"-related personal injury claims.

- Lockheed Martin LMT.N will pay $29.5 million to resolve federal allegations that it discriminated against white workers as part of its diversity, equity and inclusion policies.

- Unilever ULVR.L will overhaul its operating model and cut €1 billion ($1.12 billion) in costs by the end of 2029, it said on Tuesday, as it sharpens its focus on home and personal care after splitting off its food business.

($1 = 0.8935 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.